
Shonan iPark Outlines New Operational Structure to Provide Scale and Sustainable Long-Term Growth for the Ecosystem
TOKYO, Dec 21, 2022 – (JCN Newswire via SEAPRWire.com) – Renewing its commitment to innovation in Japan and to Shonan Health Innovation Park (“Shonan iPark”), Takeda Pharmaceutical Company Limited (“Takeda”) today announced the creation of a new company, effective April 1, 2023, together with Industrial & Infrastructure Fund Investment (“IIF”) and Mitsubishi Corporation (“Mitsubishi Corp.”),... » read more